1061 — Essex Bio-Technology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual balance sheet for Essex Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	671	543	515	561	784
Net Total Accounts Receivable
Net Total Receivables	714	500	637	617	708
Total Inventory
Total Other Current Assets
Total Current Assets	1,547	1,214	1,245	1,283	1,620
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	352	401	406	414	517
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,863	2,712	2,828	2,983	3,491
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	690	561	811	709	767
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	1,129	981	904	859	1,078
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,734	1,731	1,924	2,124	2,413
Total Liabilities & Shareholders' Equity	2,863	2,712	2,828	2,983	3,491
Total Common Shares Outstanding